BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 30348618)

  • 1. Prognostic Value of Baseline ALBI Score Among Patients With Colorectal Liver Metastases: A Pooled Analysis of Two Randomized Trials.
    Abdel-Rahman O
    Clin Colorectal Cancer; 2019 Mar; 18(1):e61-e68. PubMed ID: 30348618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ECOG performance score 0 versus 1: impact on efficacy and safety of first-line 5-FU-based chemotherapy among patients with metastatic colorectal cancer included in five randomized trials.
    Abdel-Rahman O
    Int J Colorectal Dis; 2019 Dec; 34(12):2143-2150. PubMed ID: 31732876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the Albumin-Bilirubin (ALBI) Grade as a Prognostic Indicator for Hepatocellular Carcinoma Patients Treated With Radioembolization.
    Gui B; Weiner AA; Nosher J; Lu SE; Foltz GM; Hasan O; Kim SK; Gendel V; Mani NB; Carpizo DR; Saad NE; Kennedy TJ; Zuckerman DA; Olsen JR; Parikh PJ; Jabbour SK
    Am J Clin Oncol; 2018 Sep; 41(9):861-866. PubMed ID: 28418940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline Albumin-Bilirubin (ALBI) Score in Western Patients With Hepatocellular Carcinoma Treated With Stereotactic Body Radiation Therapy (SBRT).
    Murray LJ; Sykes J; Brierley J; Kim JJ; Wong RKS; Ringash J; Craig T; Velec M; Lindsay P; Knox JJ; Dawson LA
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):900-909. PubMed ID: 29976502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation.
    Oh IS; Sinn DH; Kang TW; Lee MW; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
    Dig Dis Sci; 2017 Nov; 62(11):3235-3242. PubMed ID: 28983724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of the albumin-bilirubin grade for predicting prognosis after curative resection of patients with early-stage hepatocellular carcinoma.
    Ma XL; Zhou JY; Gao XH; Tian L; Wu J; Zhang CY; Zhou Y; Dai Q; Wang BL; Pan BS; Yang XR; Guo W
    Clin Chim Acta; 2016 Nov; 462():15-22. PubMed ID: 27520748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Time to Start Systemic Therapy on the Outcomes of Patients with Metastatic Colorectal Cancer Treated with First Line FOLFOX Chemotherapy; a Patient-Level Pooled Analysis of Two Clinical Trials.
    Oweira H; Giryes A; Mannhart M; Decker M; Abdel-Rahman O
    Expert Rev Gastroenterol Hepatol; 2018 Oct; 12(10):1069-1074. PubMed ID: 30099922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic and predictive value of the albumin-bilirubin score in advanced pancreatic cancer.
    Zhang TN; Yin RH; Wang LW
    Medicine (Baltimore); 2020 Jul; 99(28):e20654. PubMed ID: 32664063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Sex on Chemotherapy Toxicity and Efficacy Among Patients With Metastatic Colorectal Cancer: Pooled Analysis of 5 Randomized Trials.
    Abdel-Rahman O
    Clin Colorectal Cancer; 2019 Jun; 18(2):110-115.e2. PubMed ID: 30679026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of albumin-bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma.
    Hiraoka A; Kumada T; Michitaka K; Toyoda H; Tada T; Ueki H; Kaneto M; Aibiki T; Okudaira T; Kawakami T; Kawamura T; Yamago H; Suga Y; Miyamoto Y; Tomida H; Azemoto N; Mori K; Miyata H; Ninomiya T; Kawasaki H
    J Gastroenterol Hepatol; 2016 May; 31(5):1031-6. PubMed ID: 26647219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Relationship between albumin-Bilirubin grade and survival in hepatocelluler carcinoma patients treated with sorefanib.
    Fidan E; Fidan S; Merev E; Kazaz N
    Niger J Clin Pract; 2022 Feb; 25(2):173-177. PubMed ID: 35170443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative Albumin-Bilirubin Grade Predicts Recurrences After Radical Gastrectomy in Patients with pT2-4 Gastric Cancer.
    Kanda M; Tanaka C; Kobayashi D; Uda H; Inaoka K; Tanaka Y; Hayashi M; Iwata N; Yamada S; Fujii T; Sugimoto H; Murotani K; Fujiwara M; Kodera Y
    World J Surg; 2018 Mar; 42(3):773-781. PubMed ID: 28920160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals.
    Casadei Gardini A; Foschi FG; Conti F; Petracci E; Vukotic R; Marisi G; Buonfiglioli F; Vitale G; Ravaioli F; Gitto S; Verucchi G; Lenzi M; Bolondi L; Mazzella G; Brillanti S; Andreone P;
    Dig Liver Dis; 2019 May; 51(5):681-688. PubMed ID: 30327251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Independent Analysis of Albumin-Bilirubin Grade in a 765-Patient Cohort Treated with Transarterial Locoregional Therapy for Hepatocellular Carcinoma.
    Hickey R; Mouli S; Kulik L; Desai K; Thornburg B; Ganger D; Baker T; Abecassis M; Ralph Kallini J; Gabr A; Gates VL; Benson Iii AB; Lewandowski RJ; Salem R
    J Vasc Interv Radiol; 2016 Jun; 27(6):795-802. PubMed ID: 27038686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of age on toxicity and efficacy of 5-FU-based combination chemotherapy among patients with metastatic colorectal cancer; a pooled analysis of five randomized trials.
    Abdel-Rahman O; Karachiwala H
    Int J Colorectal Dis; 2019 Oct; 34(10):1741-1747. PubMed ID: 31492988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Body Mass Index on 5-FU-Based Chemotherapy Toxicity and Efficacy Among Patients With Metastatic Colorectal Cancer; A Pooled Analysis of 5 Randomized Trials.
    Abdel-Rahman O
    Clin Colorectal Cancer; 2019 Dec; 18(4):e385-e393. PubMed ID: 31378656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Combination of APRI and ALBI Facilitates Preoperative Risk Stratification for Patients Undergoing Liver Surgery After Neoadjuvant Chemotherapy.
    Pereyra D; Rumpf B; Ammann M; Perrodin SF; Tamandl D; Haselmann C; Stift J; Brostjan C; Laengle F; Beldi G; Gruenberger T; Starlinger P
    Ann Surg Oncol; 2019 Mar; 26(3):791-799. PubMed ID: 30617869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combination of the preoperative albumin-bilirubin grade and the fibrosis-4 index predicts the prognosis of patients with hepatocellular carcinoma after liver resection.
    Zhang J; Luo Y; Li C; Liu J; Xiang H; Wen T
    Biosci Trends; 2019; 13(4):351-357. PubMed ID: 31527331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of baseline seric Syndecan-1 in initially unresectable metastatic colorectal cancer patients: a simple biological score.
    Jary M; Lecomte T; Bouché O; Kim S; Dobi E; Queiroz L; Ghiringhelli F; Etienne H; Léger J; Godet Y; Balland J; Lakkis Z; Adotevi O; Bonnetain F; Borg C; Vernerey D
    Int J Cancer; 2016 Nov; 139(10):2325-35. PubMed ID: 27472156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing various scoring system for predicting overall survival according to treatment modalities in hepatocellular carcinoma focused on Platelet-albumin-bilirubin (PALBI) and albumin-bilirubin (ALBI) grade: A nationwide cohort study.
    Lee SK; Song MJ; Kim SH; Park M
    PLoS One; 2019; 14(5):e0216173. PubMed ID: 31048923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.